FLT3 and acute myeloid leukemia: In the pediatric literature, whole genome sequencing of 799 pediatric AML patients revealed a 7.6% prevalence of NC FLT3 point mutations and insertions-deletions compared to a 23% total prevalence of all FLT3 mutations (including FLT-ITD and D835).